NovoEight IV 1500 (YJ code: 6343440D4022, 1,500 IU x 1 bottle (with dissolving liquid)), manufactured by Novo Nordisk Pharma, contains Turoctocog alpha (genetically recombination). This recombinant Factor VIII therapy is used for the prevention and treatment of bleeding episodes in individuals with hemophilia A.
NovoEight IV 1500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →